Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart M Sprague

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 6, 2010
KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD)Katrin Uhlig, Jeffrey S Berns, Bryan Kestenbaum, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|July 11, 2024
Tenapanor: A Phosphate Absorption Inhibitor for the Management of Hyperphosphatemia in Patients With Kidney FailureKathleen M Hill Gallant, Stuart M Sprague, David P Rosenbaum, et al.
Kidney International Reports|September 5, 2017
Evaluation of Renal Blood Flow in Chronic Kidney Disease Using Arterial Spin Labeling Perfusion Magnetic Resonance ImagingLu-Ping Li, Huan Tan, Jon M Thacker, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
One-year efficacy and safety of the iron-based phosphate binder sucroferric oxyhydroxide in patients on peritoneal dialysisJürgen Floege, Adrian C Covic, Markus Ketteler, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|March 30, 2010
Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patientsJong Chan Park, Csaba P Kovesdy, Uyen Duong, et al.
Kidney International|March 21, 2014
A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patientsJürgen Floege, Adrian C Covic, Markus Ketteler, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|March 5, 2010
Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patientsRamanath Dukkipati, Csaba P Kovesdy, Sara Colman, et al.
American Journal of Nephrology|February 23, 2025
Adjunctive Active Vitamin D Decreases Kidney Function during Treatment of Secondary Hyperparathyroidism with Extended-Release Calcifediol in Non-Dialysis Chronic Kidney Disease in a Randomized TrialAkhtar Ashfaq, John Choe, Stephen A Strugnell, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2004
Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4Jack W Coburn, Hla M Maung, Logan Elangovan, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 22, 2009
Simultaneous control of PTH and CaxP Is sustained over three years of treatment with cinacalcet HClStuart M Sprague, Pieter Evenepoel, Mario P Curzi, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 6, 2010
KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD)Katrin Uhlig, Jeffrey S Berns, Bryan Kestenbaum, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|July 11, 2024
Tenapanor: A Phosphate Absorption Inhibitor for the Management of Hyperphosphatemia in Patients With Kidney FailureKathleen M Hill Gallant, Stuart M Sprague, David P Rosenbaum, et al.
Kidney International Reports|September 5, 2017
Evaluation of Renal Blood Flow in Chronic Kidney Disease Using Arterial Spin Labeling Perfusion Magnetic Resonance ImagingLu-Ping Li, Huan Tan, Jon M Thacker, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
One-year efficacy and safety of the iron-based phosphate binder sucroferric oxyhydroxide in patients on peritoneal dialysisJürgen Floege, Adrian C Covic, Markus Ketteler, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|March 30, 2010
Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patientsJong Chan Park, Csaba P Kovesdy, Uyen Duong, et al.
Kidney International|March 21, 2014
A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patientsJürgen Floege, Adrian C Covic, Markus Ketteler, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|March 5, 2010
Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patientsRamanath Dukkipati, Csaba P Kovesdy, Sara Colman, et al.
American Journal of Nephrology|February 23, 2025
Adjunctive Active Vitamin D Decreases Kidney Function during Treatment of Secondary Hyperparathyroidism with Extended-Release Calcifediol in Non-Dialysis Chronic Kidney Disease in a Randomized TrialAkhtar Ashfaq, John Choe, Stephen A Strugnell, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2004
Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4Jack W Coburn, Hla M Maung, Logan Elangovan, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 22, 2009
Simultaneous control of PTH and CaxP Is sustained over three years of treatment with cinacalcet HClStuart M Sprague, Pieter Evenepoel, Mario P Curzi, et al.
Pageof 12